Neurotrophic keratitis after penetrating keratoplasty for lattice dystrophy

PURPOSE: To report clinical outcomes of a patient with unilateral neurotrophic keratitis following penetrating keratoplasty for lattice dystrophy treated with topical recombinant human nerve growth factor. OBSERVATIONS: A 75-year-old male with lattice dystrophy and history of herpes simplex keratiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouvea, Larissa, Penatti, Raphael, Rocha, Karolinne Maia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933712/
https://www.ncbi.nlm.nih.gov/pubmed/33718661
http://dx.doi.org/10.1016/j.ajoc.2021.101058
Descripción
Sumario:PURPOSE: To report clinical outcomes of a patient with unilateral neurotrophic keratitis following penetrating keratoplasty for lattice dystrophy treated with topical recombinant human nerve growth factor. OBSERVATIONS: A 75-year-old male with lattice dystrophy and history of herpes simplex keratitis, presented with recurrent neurotrophic ulceration in the right eye two years following penetrating keratoplasty. The patient was successfully treated with topical recombinant human nerve growth factor. CONCLUSION: Neurotrophic keratitis is a rare chronic disorder that affects quality of life due to the risk of vision loss. Topical recombinant human nerve growth factor is a novel and effective treatment option that may help improve optical quality and patient's satisfaction as shown in this case of recurrent neurotrophic keratitis.

Ejemplares similares